Q2 2026 Investor Audibles: Hirschmann Capital, 1 Main Capital, Third Point
The Q2 2026 investor audibles highlight the performance and outlook of Hirschmann Capital, One Main Capital, and Third Point, focusing on their strategies in response to current economic conditions. Each fund manager discusses their respective investment themes, challenges, and expected market movements particularly regarding equities, gold, and AI technology.
Summary
In Hirschmann Capital's update, Brian Hirschmann outlines the fund's performance with returns of 7.6% for Class A and 9.2% for Class B against a 10.2% rise in the S&P 500 during H1 2026. He expects a severe downturn in U.S. equities and a sovereign debt crisis, citing high treasury yields and weak housing market indicators. Hirschmann underscores gold mining equities as a strategic investment, suggesting they will benefit significantly in a crisis scenario, despite the recent declines in gold prices and junior miner indices.
One Main Capital’s update emphasizes a cautious perspective on the AI investment theme and its exclusion from major AI beneficiaries, focusing instead on the stability of core holdings. The manager maintains a commitment to disciplined investment strategies and highlights current positioning in diversified core businesses with sound fundamentals. Hilton Grand Vacations and Diomedica Therapeutics are among the key holdings, showcasing a blend of opportunistic investments with strong growth potential despite market volatility.
Lastly, Third Point’s report reflects on their tactical approach amid a volatile market characterized by a significant drop in AI-related stocks. The report analyzes specific holdings including Block Inc., highlighting its potential as it transitions to deeper monetization strategies. Additionally, the firm remains cautious about the overall credit market, anticipating pressures from an influx of new issuances while focusing on selective investment opportunities in structured credit markets.
About this episode
<p>Q2 2026 Investor Audibles is live. </p><p>Remember, none of this is investment advice. I just wish there were audible versions of investor letters, so I decided to make them. </p><p>I hope you enjoy!</p>
Key Insights
- Hirschmann Capital's Class A and Class B returned 7.6% and 9.2% respectively in H1 2026, trailing behind the S&P 500's 10.2% gain.
- The author posits that a severe downturn in U.S. equities and a sovereign debt crisis are imminent due to rising treasury yields and declining housing market conditions.
- Hirschmann emphasizes that gold mining equities are expected to perform well during a sovereign debt crisis, as demand for gold typically surges during such events.
- One Main Capital's investment strategy focuses on maintaining core holdings in fundamentally strong businesses while being selective about opportunistic investments in high-convexity themes.
- Hilton Grand Vacations is highlighted as an attractive investment due to its strong free cash flow generation and ongoing stock repurchase plans.
- Third Point discusses the impact of a significant sell-off in AI-related equities, attributing it to global deleveraging events rather than fundamental company issues.
- The analysis of Block Inc. reveals its transition towards deeper monetization through its Cash App platform, aiming to capitalize on a new credit product aimed at underserved consumers.
- Third Point's cautious outlook on the corporate credit market suggests that adverse selection risks are rising as a substantial portion of loans is scheduled to mature in the coming years.
Topics
Transcript
Hey guys, we are back for another Q2 Investor Audibles edition. I'm going to try to go through some of these letters here. First one is Hirschman Capital. And let's get after it. Dear partner, below are updated results for the Hirschman Partnership. In H1-2026, Class A and Class B returned 7.6% and 9.2% respectively versus 10.2% for the S&P 500. Despite its ultra bearish strategy, the fund has outperformed U.S. and global equities since inception. I next highlight why a severe global downturn in U.S. equities and U.S. sovereign debt crisis seem likely provide an update on the fund's gold mining equities and explain why I expect them to perform well in such a crisis. Long-term treasury yields are…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Value Hive Podcast
[REPLAY] Gavin McCracken: A Journey To 2,000x Returns
Gavin McCracken discusses his journey to achieving a 2000x return primarily through concentrated positions in Andean Precious Metals and Velour Energy, emphasizing the importance of commodity cycle timing, low-cost operators, strong management conviction (evidenced by insider buying), and protective position sizing. He contrasts his speculative, concentrated approach with a more diversified value investing methodology, and explains his current thesis on oil (via Suncor) and gold miners (via Monera Alamos) based on geopolitical supply disruptions and fuel crises.
Jeremy Raper: Cycles, AI, and Activism
Jeremy Raper discusses AI's application in special situations and legal work, the cyclicality of semiconductor/memory companies despite post-cyclical narratives, and specific investment opportunities in Australian small-cap markets where professional coverage is sparse.
Evan Vanderveer (Vanshap Capital): MELI, KSPI, and NU
Evan Vanderveer of Vanshap Capital discusses his investment philosophy centered on "customer fanatics"—founder-controlled businesses obsessed with long-term customer satisfaction—and presents three investment ideas: MercadoLibre (e-commerce and fintech platform in Latin America trading at historically low multiples despite strong fundamentals), Kaspi (Kazakhstan's super app with 2/3 daily user penetration and expansion into Turkey), and Nu Holdings (Brazil's largest digital bank expanding into Mexico and the US).
Seedy19: A 35x Return From Biotech Investing
C.D., a biotech investor who achieved a 35x return in 2025 through a combination of common stock, covered calls, and put-writing strategies, discusses how he entered the biotech space despite lacking a science background, explains his process for identifying undervalued opportunities, and identifies emerging themes like neurological diseases, cardiovascular space, and rare disease gene therapy as the most promising areas in biotech.
Peter Mantas: The Biotech Bubble Whisperer
Peter Mantas discusses the current state and future potential of the biotech market, emphasizing the importance of AI-driven drug discovery and platform companies. He identifies key investment strategies and the role of political dynamics in shaping biotechnology outcomes.